Casadei-Gardini, Andrea http://orcid.org/0000-0001-6289-7202
Tada, Toshifumi
Shimose, Shigeo
Kumada, Takashi
Niizeki, Takashi
Cascinu, Stefano
Cucchetti, Alessandro
Article History
Accepted: 15 February 2021
First Online: 27 February 2021
Declarations
:
: No external funding was used in the preparation of this article.
: Andrea Casadei Gardini. reports receiving consulting fees from AstraZeneca, Bayer, Eisai, MSD, Ipsen, and IQVIA, and lecture fees from Eisai, Ipsen, Merck Serono, and Roche. Changhoon Yoo reports honoraria from BMS, MSD, Bayer, Eisai, Ipsen, AstraZeneca, and Servier; and research grants from Bayer, Ono, AstraZeneca, and Servier. Toshifumi Tada, Shigeo Shimose, Takashi Kumada, Takashi Niizeki, Stefano Cascinu, and Alessandro Cucchetti declare that they have no conflicts of interest that might be relevant to the contents of this article.
: All patients who participated in the study gave informed consent. The National Data Inspectorate and the Regional Committee for Medical Research Ethics approved the study. The study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The dataset used during the current study is available from the corresponding author on reasonable request.
: Not applicable.
: Conception and design: ACG, AC. Development of methodology and acquired data: all authors. Statistical analysis and interpretation of data: ACG, AC. Writing, review, and revision of the paper: all authors. Approved the final version: all authors. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: all authors.